# A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

> **NCT04941755** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 22 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986256
- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT04941755
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-25
- **Primary completion:** 2021-09-24
- **Final completion:** 2021-09-24
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941755, "A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04941755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*